O

Obio Technology Shanghai Corp Ltd
SSE:688238

Watchlist Manager
Obio Technology Shanghai Corp Ltd
SSE:688238
Watchlist
Price: 5.46 CNY 1.11% Market Closed
Market Cap: 3.5B CNY
Have any thoughts about
Obio Technology Shanghai Corp Ltd?
Write Note

Obio Technology Shanghai Corp Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Obio Technology Shanghai Corp Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
O
Obio Technology Shanghai Corp Ltd
SSE:688238
Other Operating Expenses
ÂĄ6.5m
CAGR 3-Years
-35%
CAGR 5-Years
17%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Other Operating Expenses
ÂĄ358m
CAGR 3-Years
34%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Other Operating Expenses
ÂĄ74m
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Other Operating Expenses
ÂĄ404.5m
CAGR 3-Years
31%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Other Operating Expenses
ÂĄ16.8m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Other Operating Expenses
ÂĄ45.3m
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Obio Technology Shanghai Corp Ltd
Glance View

Market Cap
3.5B CNY
Industry
Life Sciences Tools & Services

Obio Technology Shanghai Corp. Ltd. engages in biomedical basic research, gene therapy drug incubation, and clinical grade gene therapy virus vector CDMO service provision. The company is headquartered in Shanghai, Shanghai and currently employs 631 full-time employees. The company went IPO on 2022-03-22. The firm is mainly engaged in providing contract research organization (CRO) services such as gene therapy vector development and gene function research for the basic research of gene therapy, as well as contract research and development production organization (CDMO) services such as pharmaceutical research and clinical sample production for the research and development of gene drugs. The firm mainly conducts business in the European and American markets and the domestic market.

Intrinsic Value
4.56 CNY
Overvaluation 17%
Intrinsic Value
Price
O

See Also

What is Obio Technology Shanghai Corp Ltd's Other Operating Expenses?
Other Operating Expenses
6.5m CNY

Based on the financial report for Dec 31, 2023, Obio Technology Shanghai Corp Ltd's Other Operating Expenses amounts to 6.5m CNY.

What is Obio Technology Shanghai Corp Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
17%

Over the last year, the Other Operating Expenses growth was -4%. The average annual Other Operating Expenses growth rates for Obio Technology Shanghai Corp Ltd have been -35% over the past three years , 17% over the past five years .

Back to Top